Methyl 4-(2-(4-(methylsulfonyl)phenyl)acetyl)benzoate

Catalog No.: 
ACVMIB624
CAS No.: 
162011-70-3
Molecular Formula: 
C17H16O5S
Molecular Weight: 
332.38
Methyl 4-(2-(4-(methylsulfonyl)phenyl)acetyl)benzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$446.00In stockInquiry
250mg95%$743.00In stockInquiry
500mg95%$1237.00In stockInquiry
1g95%$1856.00In stockInquiry
5g95%$5566.00InquiryInquiry
10g95%$9277.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 4-(2-(4-(methylsulfonyl)phenyl)acetyl)benzoate
IUPAC Namemethyl 4-(2-(4-(methylsulfonyl)phenyl)acetyl)benzoate
Molecular FormulaC17H16O5S
Molecular Weight332.38
SMILESO=C(OC)C1=CC=C(C(CC2=CC=C(S(=O)(C)=O)C=C2)=O)C=C1
InChI KeyVUCNRTMVHCWYGC-UHFFFAOYSA-N
Synonymmethyl 4-[2-(4-methylsulfonylphenyl)acetyl]benzoate;Benzoic acid, 4-[2-[4-(methylsulfonyl)phenyl]acetyl]-, methyl ester
CAS No.162011-70-3

Synthetic Route by SureRoute

1. ACVMIB624 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACYWVD540 route compound structure diagram
    ACYWVD54053606-06-7In Stock
  4. Then
  5. ACVMIB624 route product structure diagram
    ACVMIB624162011-70-3In Stock
Inquiry

2. ACVMIB624 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVMIB624 route product structure diagram
    ACVMIB624162011-70-3In Stock
Inquiry

3. ACVMIB624 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMILX821 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVMIB624 route product structure diagram
    ACVMIB624162011-70-3In Stock
Inquiry

Comments (0)